Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells

British Journal of Cancer

Volumn 110, Issue 1, 2014, Pages 156-163

  Hirakawa, M ^a,b   Takimoto, R ^a,b   Tamura, F ^a,b   Yoshida, M ^a,b   Ono, M ^a,b   Murase, K ^a   Sato, Y ^a   Osuga, T ^a   Sato, T ^a,b   Iyama, S ^a   Miyanishi, K ^a   Takada, K ^a   Hayashi, T ^a   Kobune, M ^b   Kato, J ^a,b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

colorectal cancer; EMT; fucosyltransferase; TGF b

Indexed keywords

FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 3; FUCOSYLTRANSFERASE 6; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CANCER CELL; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FUCOSYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LECTIN BLOT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

CELL ADHESION; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FUCOSYLTRANSFERASES; HT29 CELLS; HUMANS; PHOSPHORYLATION; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84891845775     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.699     Document Type: Article

References (52)

1. Caja L, Bertran E, Campbell J, Fausto N, Fabregat I (2011) The transforming growth factor-beta (TGF-beta) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells. J Cell Physiol 226(5): 1214-1223.
2. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massague J, Sancho E, Batlle E (2012) Dependency of colorectal cancer on a TGF-beta-driven Program in stromal cells for metastasis initiation. Cancer cell 22(5): 571-584.
3. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N (2010) Colorectal cancer. Lancet 375(9719): 1030-1047.
4. de Vries T, Knegtel RM, Holmes EH, Macher BA (2001) Fucosyltransferases: structure/function studies. Glycobiology 11(10): 119R-128R. Filella X, Molina R, Grau JJ, Pique JM, Garcia-Valdecasas JC, Astudillo E, Biete A, Bordas JM, Novell A, Campo E et al. (1992) Prognostic value of CA 19.9 levels in colorectal cancer. Annals of surgery 216(1): 55-59.
5. Grabowski P, Mann B, Mansmann U, Lovin N, Foss HD, Berger G, Scherubl H, Riecken EO, Buhr HJ, Hanski C (2000) Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int J Cancer 88(2): 281-286.
6. Grandclement C, Pallandre JR, Valmary Degano S, Viel E, Bouard A, Balland J, Remy-Martin JP, Simon B, Rouleau A, BoireauW, Klagsbrun M, Ferrand C, Borg C (2011) Neuropilin-2 expression promotes TGF-beta1-mediated epithelial to mesenchymal transition in colorectal cancer cells. PLoS One 6(7): e20444.
7. Hakomori S, Kannagi R (1983) Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst 71(2): 231-251. (Pubitemid 13009736)
8. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Weber LA, Gerthoffer WT (1999) A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 274(34): 24211-24219.
9. Hiller KM, Mayben JP, Bendt KM, Manousos GA, Senger K, Cameron HS, Weston BW (2000) Transfection of alpha(1,3)fucosyltransferase antisense sequences impairs the proliferative and tumorigenic ability of human colon carcinoma cells. Mol Carcinog 27(4): 280-288. (Pubitemid 30191998)
10. Ilyas M, Efstathiou JA, Straub J, Kim HC, Bodmer WF (1999) Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. Proc Natl Acad Sci USA 96(6): 3087-3091. (Pubitemid 29148848)
11. Jen J, Kim H, Piantadosi S, Liu ZF, Levitt RC, Sistonen P, Kinzler KW, Vogelstein B, Hamilton SR (1994) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331(4): 213-221. (Pubitemid 24226678)
12. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282(30): 22089-22101. (Pubitemid 47195788)
13. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N (2004) Carbohydratemediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95(5): 377-384. (Pubitemid 38832679)
14. Kanoh A, Ota M, Narimatsu H, Irimura T (2003) Expression levels of FUT6 gene transfected into human colon carcinoma cells switch two sialyl-Lewis X-related carbohydrate antigens with distinct properties in cell adhesion. Biochem Biophys Res Commun 303(3): 896-901. (Pubitemid 36384939)
15. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl JMed 359(17): 1757-1765.
16. Katsuno Y, Lamouille S, Derynck R (2013) TGF-beta signaling and epithelialmesenchymal transition in cancer progression. Curr Opin Oncol 25(1): 76-84.
17. Kolosova I, Nethery D, Kern JA (2011) Role of Smad2/3 and p38 MAP kinase in TGF-beta1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226(5): 1248-1254.
18. Koprowski H, Herlyn M, Steplewski Z, Sears HF (1981) Specific antigen in serum of patients with colon carcinoma. Science 212(4490): 53-55. (Pubitemid 11114676)
19. Kouri M, Pyrhonen S, Kuusela P (1992) Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol 49(2): 78-85.
20. Kwon SM, Kim SA, Fujii S, Maeda H, Ahn SG, Yoon JH (2011) Transforming growth factor beta1 promotes migration of human periodontal ligament cells through heat shock protein 27 phosphorylation. Biol Pharm Bull 34(4): 486-489.
21. Leivonen SK, Kahari VM (2007) Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer 121(10): 2119-2124.
22. Lin H, Wang D, Wu T, Dong C, Shen N, Sun Y, Xie H, Wang N, Shan L (2011) Blocking core fucosylation of TGF-beta1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol 300(4): F1017-F1025.
23. Liu YC, Yen HY, Chen CY, Chen CH, Cheng PF, Juan YH, Chen CH, Khoo KH, Yu CJ, Yang PC, Hsu TL, Wong CH (2011) Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci USA 108(28): 11332-11337.
24. Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K (2008) N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci 99(8): 1611-1617.
25. Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, Suzuki A, Yoshida A, Takeuchi M, Kannagi R (2004) Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res 64(13): 4498-4505. (Pubitemid 38856921)
26. Moustakas A, Heldin CH (2012) Induction of epithelial-mesenchymal transition by transforming growth factor beta. Sem Cancer Biol 22(5-6): 446-454.
27. Muinelo-Romay L, Villar-Portela S, Cuevas Alvarez E, Gil-Martin E, Fernandez-Briera A (2011) Alpha(1,6)Fucosyltransferase expression is an independent prognostic factor for disease-free survival in colorectal carcinoma. Hum Pathol 42(11): 1740-1750.
28. Nakagoe T, Fukushima K, Tanaka K, Sawai T, Tsuji T, Jibiki M, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K (2002) Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients. J Exp Clin Cancer Res 21(1): 107-113. (Pubitemid 34309239)
29. Narimatsu H, Iwasaki H, Nakayama F, Ikehara Y, Kudo T, Nishihara S, Sugano K, Okura H, Fujita S, Hirohashi S (1998) Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients. Cancer Res 58(3): 512-518. (Pubitemid 28087416)
30. Ogunbiyi OA, Goodfellow PJ, Herfarth K, Gagliardi G, Swanson PE, Birnbaum EH, Read TE, Fleshman JW, Kodner IJ, Moley JF (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16(2): 427-433. (Pubitemid 28135583)
31. Park JJ, Yi JY, Jin YB, Lee YJ, Lee JS, Lee YS, Ko YG, Lee M (2012) Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol 83(7): 849-857.
32. Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, FrankelW, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, Vokes EE, Lane WS, Huang CC, Caldes T, Di Cristofano A, Hampel H, Nilsson I, von Heijne G, Fodde R, Murty VV, de la Chapelle A, Weghorst CM (2005) Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294(13): 1634-1646. (Pubitemid 41407356)
33. Petrioli R, Licchetta A, Roviello G, Pascucci A, Francini E, Bargagli G, Conca R, Miano ST, Marzocca G, Francini G (2012) CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab. Cancer Invest 30(1): 65-71.
34. Picon A, Gold LI, Wang J, Cohen A, Friedman E (1998) A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1. Cancer Epidemiol Biomarkers Prev 7(6): 497-504. (Pubitemid 28354113)
35. Popat S, Houlston RS (2005) A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41(14): 2060-2070. (Pubitemid 41337947)
36. Popat S, Hubner R, Houlston RS (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23(3): 609-618. (Pubitemid 46224239)
37. Sakuma K, Aoki M, Kannagi R (2012) Transcription factors c-Myc and CDX2 mediate E-selectin ligand expression in colon cancer cells undergoing EGF/bFGF-induced epithelial-mesenchymal transition. Proc Natl Acad Sci USA 109(20): 7776-7781.
38. Shin KD, Lee MY, Shin DS, Lee S, Son KH, Koh S, Paik YK, Kwon BM, Han DC (2005) Blocking tumor cell migration and invasion with biphenyl isoxazole derivative KRIBB3, a synthetic molecule that inhibits Hsp27 phosphorylation. J Biol Chem 280(50): 41439-41448. (Pubitemid 41832203)
39. Tan FL, Ooi A, Huang D, Wong JC, Qian CN, Chao C, Ooi L, Tan YM, Chung A, Cheow PC, Zhang Z, Petillo D, Yang XJ, Teh BT (2010) p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer 126(10): 2353-2361.
40. Tsuchida A, Okajima T, Furukawa K, Ando T, Ishida H, Yoshida A, Nakamura Y, Kannagi R, Kiso M, Furukawa K (2003) Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alpha-series gangliosides. J Biol Chem 278(25): 22787-22794. (Pubitemid 36830340)
41. Tsushima H, Ito N, Tamura S, Matsuda Y, Inada M, Yabuuchi I, Imai Y, Nagashima R, Misawa H, Takeda H, Matsuzawa Y, Kawata S (2001) Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer. Clin Cancer Res 7(5): 1258-1262. (Pubitemid 32708678)
42. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W (2009) Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 28(45): 4022-4033.
43. Vincent T, Neve EP, Johnson JR, Kukalev A, Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL, Crystal RG, de Herreros AG, Moustakas A, Pettersson RF, Fuxe J (2009) A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nature Cell Biol 11(8): 943-950.
44. Wang L, Ma R, Flavell RA, Choi ME (2002) Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells. J Biol Chem 277(49): 47257-47262. (Pubitemid 36159236)
45. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N (2006) Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 281(5): 2572-2577. (Pubitemid 43845717)
46. Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson 3rd AB, Hamilton SR (2001) Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 344(16): 1196-1206. (Pubitemid 32319494)
47. Weston BW, Hiller KM, Mayben JP, Manousos GA, Bendt KM, Liu R, Cusack Jr JC (1999) Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells. Cancer Res 59(9): 2127-2135. (Pubitemid 29217676)
48. Weston BW, Smith PL, Kelly RJ, Lowe JB (1992) Molecular cloning of a fourth member of a human alpha (1,3)fucosyltransferase gene family. Multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J Biol Chem 267(34): 24575-24584.
49. Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J (2012) Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach. Plos One 7(7): e39545.
50. Yu L, Hebert MC, Zhang YE (2002) TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21(14): 3749-3759. (Pubitemid 34787048)
51. Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, Gorden DL, Datta PK (2010) Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138(3): 969-80 e1-3.
52. Zhu Z, Xu X, Yu Y, Graham M, Prince ME, Carey TE, Sun D (2010) Silencing heat shock protein 27 decreases metastatic behavior of human head and neck squamous cell cancer cells in vitro. Mol Pharm 7(4): 1283-1290.